Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03025659 · ClinicalTrials.gov registry record
Lactate Acidosis in Postoperative Hearts
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 43
- Enrollment target
NCT03025659: Completed study, sponsored by University of Florida.
NCT03025659 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03025659 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
This is a single-center, observational study. Investigators aim to characterize the metabolism of lactate in children over the first forty-eight hours following cardiac surgery. Blood samples will be obtained up to 12 timepoints. Samples will be analyzed for concentration of pyruvate. Results will be compared to standard of care laboratory results for lactate and other direct and indirect measures of cardiac output.
Interventions
- OTHER Pyruvate levels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2017-05-28 |
| Est. Completion | 2019-01-24 |
What the finished NCT03025659 record still lists
NCT03025659 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pyruvate levels is the first listed.
NCT03025659 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03025659 about?
NCT03025659 is a clinical study titled "Lactate Acidosis in Postoperative Hearts". This is a single-center, observational study. Investigators aim to characterize the metabolism of lactate in children over the first forty-eight hours following cardiac surgery. Blood samples will be obtained up to 12 timepoints. Samples will be analyzed for concentration of pyruvate. Results will b...
What is the current status of trial NCT03025659?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2017-05-28. Estimated completion is 2019-01-24.
What interventions are being tested in trial NCT03025659?
The interventions under investigation include: Pyruvate levels (OTHER).
Who is sponsoring clinical trial NCT03025659?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI